Emcure Pharmaceuticals signs distribution pact with Roche for nephrology, transplant medicine

Key Highlights

• “Roche’s globally trusted innovations strongly complement our existing portfolio and reach.
• Together, we aim to expand access to these critical therapies and support physicians in delivering optimal care to patients across India,” Emcure Pharmaceuticals Managing Director & CEO, Satish Mehta said.
• Roche India & Neighbouring Markets, Managing Director & CEO, Rajji Mehdwan said, “Through Emcure’s strong distribution network and clinical engagement, we believe these medicines can reach a larger number of patients who can benefit from Roche’s long-standing innovations in transplant and CKD care.” The collaboration is aimed at improving patient access to proven therapies while supporting better anaemia management and long-term outcomes for patients with CKD and transplant needs, the company said.
• (PTI) Follow our WhatsApp channel.